• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,080
2,274
1,815
1,799
1,708

COUNTRY

823
638
256
247
206

CATEGORIES

  • 856
  • 184
  • 950
  • 1,127
    • 99
  • 385
  • 270
  • 251
  • 66
  • 378
  • 673
  • 1,244
  • 1,621
  • 625
  • 883
  • 1,672
  • 2,619
    • 573
    • 119
    • 553
    • 75
    • 528
    • 45
    • 507
    • 18
    • 19
    • 25
  • 505
  • 727
  • 0
  • 97

PRICE

6,512
11,218
16,895
24,627

PUBLISHED

1,495
2,995
6,973
24,627

PRODUCT TYPE

20,259
3,174
855
164
74
43
21
21
9
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE

Malignant Mesothelioma - Pipeline Review, H2 2014

Malignant Mesothelioma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Malignant Mesothelioma - Pipeline Review, H2 2014’, provides an overview of the Malignant Mesothelioma’s therapeutic...

July 2014
FROM

Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Pipeline Review, H2 2014

Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Familial Amyloid Polyneuropathy (Transthyretin...

July 2014
FROM

Diabetic Gastroparesis - Pipeline Review, H2 2014

Diabetic Gastroparesis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Diabetic Gastroparesis - Pipeline Review, H2 2014’, provides an overview of the Diabetic Gastroparesis’s therapeutic...

July 2014
FROM

Equine Encephalitis - Pipeline Review, H2 2014

Equine Encephalitis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Equine Encephalitis - Pipeline Review, H2 2014’, provides an overview of the Equine Encephalitis’s therapeutic pipeline. This...

July 2014
FROM

Follicular Lymphoma - Pipeline Review, H2 2014

Follicular Lymphoma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Follicular Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Follicular Lymphoma’s therapeutic pipeline. This...

July 2014
FROM

Brain Tumor - Pipeline Review, H2 2014

Brain Tumor - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Brain Tumor - Pipeline Review, H2 2014’, provides an overview of the Brain Tumor’s therapeutic pipeline. This report provides...

July 2014
FROM

Epithelial Ovarian Cancer - Pipeline Review, H2 2014

Epithelial Ovarian Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Epithelial Ovarian Cancer - Pipeline Review, H2 2014’, provides an overview of the Epithelial Ovarian Cancer’s...

July 2014
FROM

Respiratory Depression - Pipeline Review, H2 2014

Respiratory Depression - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Respiratory Depression - Pipeline Review, H2 2014’, provides an overview of the Respiratory Depression’s therapeutic...

July 2014
FROM

Chronic Heart Failure - Pipeline Review, H2 2014

Chronic Heart Failure - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Chronic Heart Failure - Pipeline Review, H2 2014’, provides an overview of the Chronic Heart Failure’s therapeutic...

July 2014
FROM

Neurofibromatoses Type II - Pipeline Review, H2 2014

Neurofibromatoses Type II - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Neurofibromatoses Type II - Pipeline Review, H2 2014’, provides an overview of the Neurofibromatoses Type II’s...

July 2014
FROM
Late-Stage Four-FCritical Care Therapeutics in Major Developed Markets to 2020 - New andactor PCCs and Recombinant Products to Drive Market Late-Stage Four-FCritical Care Therapeutics in Major Developed Markets to 2020 - New andactor PCCs and Recombinant Products to Drive Market - Product Thumbnail Image

Late-Stage Four-FCritical Care Therapeutics in Major Developed Markets to 2020 - New andactor PCCs and Recombinant Products to Drive Market

This report provides in-depth analysis of the critical care market in the US, UK, France, Germany, Italy, Spain, Japan and Canada The report provides an estimation of market size for 2013, along with...

July 2014
FROM
Global Omega-3 and Omega-6 Polyunsaturated Fatty Acid Ingredients Market Global Omega-3 and Omega-6 Polyunsaturated Fatty Acid Ingredients Market - Product Thumbnail Image

Global Omega-3 and Omega-6 Polyunsaturated Fatty Acid Ingredients Market

This study covers the state of the global omega-3 ingredients market in terms of market size, growth, competitive environment, and the key challenges facing omega-3 ingredient suppliers in 2012 and...

July 2014
FROM

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates Summary “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates” It is an essential...

July 2014
FROM

OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020

OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020 Summary Dengue is a febrile illness caused by the dengue virus (DENV), a single-stranded flavivirus most commonly transmitted...

July 2014
FROM
Biotech and Pharma Stock List Biotech and Pharma Stock List - Product Thumbnail Image

Biotech and Pharma Stock List

The Biotech and Pharma Directory lists publicly traded biotech and pharmaceutical companies on the global stock exchanges with company descriptions, stock symbols and hyperlinks to company websites...

July 2014

Neonatal Seizures Global Clinical Trials Review, H2, 2014

Neonatal Seizures Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Neonatal Seizures Global Clinical Trials Review, H2, 2014" provides data on the Neonatal Seizures clinical...

July 2014
FROM

Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2014

Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2014" provides data on the Intracerebral...

July 2014
FROM

Intracranial Hypertension Global Clinical Trials Review, H2, 2014

Intracranial Hypertension Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Intracranial Hypertension Global Clinical Trials Review, H2, 2014" provides data on the Intracranial...

July 2014
FROM

Polymyalgia Rheumatica Global Clinical Trials Review, H2, 2014

Polymyalgia Rheumatica Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Polymyalgia Rheumatica Global Clinical Trials Review, H2, 2014" provides data on the Polymyalgia...

July 2014
FROM

Generalized Seizures Global Clinical Trials Review, H2, 2014

Generalized Seizures Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Generalized Seizures Global Clinical Trials Review, H2, 2014" provides data on the Generalized Seizures...

July 2014
FROM
Loading Indicator

Our Clients

Our clients' logos